Venture&Growth
Venture&Growth
All Portfolio items
See full Venture&Growth portfolio
UK-based digital therapy company focused on mental disorders.
Big Health is a digital therapeutics company dedicated to helping millions back to good mental health. Its first digital therapeutics Sleepio, for poor sleep and Daylight, for worry and anxiety are fully automated, scalable cognitive and behavioural programs. Big Health’s products are backed by 50 published clinical papers including 13 randomised controlled trials (RCTs), and are cited in leading clinical guidelines including the American College of Physicians and NICE. Today, over 12 million people worldwide have reimbursed access to Big Health’s products, via leading employers in the US and the UK’s NHS.
More Big Health news
Gilde Healthcare company Big Health expands into adolescent mental health through acquisition of Limbix
Gilde Healthcare company Big Health builds out its Leadership Team with the appointment of five key Executives
Gilde Healthcare company Big Health receives NICE digital therapeutics guidance confirming clinical and cost effectiveness
Gilde Healthcare Portfolio Company Big Health Adds Former FDA Deputy Commissioner Anand Shah to Its Board of Directors
Gilde Healthcare Portfolio Company Big Health Raises $75 Million in Series C Funding
Gilde Healthcare leads $39 million in Series B financing in Big Health
Venture&Growth
CatalYm
CatalYm is a clinical-stage immuno-oncology company improving the outcomes of existing checkpoint inhibitor therapies in difficult-to-treat cancer types. The company has identified GDF-15 as a key cancer therapy resistance mechanism and is developing it as a safe and efficacious immune

Venture&Growth
SynOx Therapeutics
SynOx Therapeutics Limited is a Dublin-based, late clinical-stage biopharmaceutical company developing emactuzumab, a best-in-class monoclonal antibody against CSF-1R, for the treatment of Tenosynovial Giant Cell Tumour (TGCT) and other CSF-1 related and macrophage driven disorders. TGCT is a rare, non-malignant but

Venture&Growth
Inari Medical
US MedTech company focused on removal of blood clots to treat pulmonary embolism or deep vein thrombosis.
